Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Night work, chronotype and risk of endometrial cancer in the Screenwide case-control study.

Autor: Costas L; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain lcostas@iconcologia.net.; Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain., Frias-Gomez J; Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain.; Faculty of Medicine, University of Barcelona, Barcelona, Spain., Benavente Moreno Y; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain., Peremiquel-Trillas P; Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain.; Faculty of Medicine, University of Barcelona, Barcelona, Spain., Carmona Á; Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain., de Francisco J; Department of Anesthesiology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Spain., Caño V; Department of Anesthesiology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Spain., Paytubi S; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain., Pelegrina B; Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain., Martínez JM; Department of Gynecology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Spain., Pineda M; Hereditary Cancer Group, Catalan Institute of Oncology, IDIBELL, ONCOBELL Program, L'Hospitalet de Llobregat, Spain.; Consortium for Biomedical Research in Cancer (CIBERONC), Madrid, Spain., Brunet J; Hereditary Cancer Group, Catalan Institute of Oncology, IDIBELL, ONCOBELL Program, L'Hospitalet de Llobregat, Spain.; Consortium for Biomedical Research in Cancer (CIBERONC), Madrid, Spain., Vidal A; Consortium for Biomedical Research in Cancer (CIBERONC), Madrid, Spain.; Department of Pathology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Spain., Matias-Guiu X; Consortium for Biomedical Research in Cancer (CIBERONC), Madrid, Spain.; Department of Pathology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Spain., Bosch X; Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain., Ponce J; Department of Gynecology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Spain., Kogevinas M; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Barcelona Institute for Global Health (ISGlobal)-Campus MAR, Barcelona, Spain.; Department of Experimental and Health Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.; Hospital del Mar, Medical Research Institute (IMIM), Barcelona, Spain., De Sanjosé S; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Consultant, National Cancer Institute, Rockville, Maryland, USA., Alemany L; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain.

Publikováno v: Occupational and environmental medicine [Occup Environ Med] 2022 Feb 24. Date of Electronic Publication: 2022 Feb 24.